Clinical trials
Completed Primary Myelofibrosis trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 2 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sierra Oncology LLC - a GSK company | 5 |
| AbbVie | 3 |
| Celgene | 2 |
| Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA) | 2 |
| Incyte Corporation | 2 |
| Novartis Pharmaceuticals | 2 |
| S*BIO | 1 |
| Syntara | 1 |
| The Canadian Blood and Marrow Transplant Group | 1 |
| Universitaire Ziekenhuizen KU Leuven | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Primary Myelofibrosis | 20 |
| Myeloproliferative Disorders | 7 |
| Thrombocythemia, Essential | 4 |
| Hematologic Diseases | 3 |
| Polycythemia Vera | 3 |
| Bone Marrow Diseases | 2 |
| Neoplasms | 2 |
| Anemia | 1 |
| Anemia, Refractory | 1 |
| Anemia, Refractory, with Excess of Blasts | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.